BlackRock's position in Sanofi is currently worth $141M. That's 0.00% of their equity portfolio (1858th largest holding). The first Sanofi trade was made in Q4 2020. Since then BlackRock bought shares six more times and sold shares on eleven occasions. The investor's estimated purchase price is $157M, resulting in a loss of 10%.
NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A ALTUVIII...
French drugmaker Sanofi plans to invest 400 million euros ($437.24 million) in its global capacity centre (GCC) in India by the end of the decade, as it aims...
Sanofi has begun shipping its influenza vaccine to U.S. healthcare providers for the 2024-2025 flu season. Read more here.
Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunize...